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1992-271 MultipleStentslncreasesTargetVessel
RevaacularizetionRatas
D. Aliabadi, T.R. Bowere, F.V.Tilli, M. Spybrook, H.L. Greenberg,
J.A. Goldstein, C.L. Grines, R.D. Safian, W.W. O’Neill. William Beaurnorrt
Hospital, Royal Oak, Ml, USA
Recent trials have ahown that coronary stenting improves clinieel restenosis
compared with balloon angioplasfy. However, these trials included selected
lesion types with predominantly single stent implants. To determine whether
implantation of multiple stents influences clinical restenoais, we reviewed
the need for target vessel revaaularfzation (TVR) at 9 months in 316 con-
secutive patients who underwent intramronary stenting. A total of 585 stents
(436 Palmez-Schatz, 80 Billiaqt 69 Gianturco-Roubin) were implanted in 344
Ieaiona. Overall, W patients (19%) required TVR, in all cases related to in-
stent restenosis occurring Iata (>1 month) and presumably related to intimal
hyperplasia. To determine whether pre-proeedural angiographic features or
procedural factors influenced need for TVR, detailad angiographic anaiysia
were performed in 316 patients. By univariate analysis, angiographic corre-
lates of TVR included implantation of multiple overlapping stents at a single
target site (p c 0.01) non BENESTENT/STRESS equivalent (p < 0.01), and
target Ieaion length >lOmm (p < 0.04). Bymultivariata analysis, implantation
of multiple overlapping stents (OR 1.4 [1.0-1.6, gs~o Cl] p < 0.03) ramained
a predictor of need for TVR. The TVR rate for single stent implant was 117..
The TVR rate for implantation of 2 stents waa 23% (p <0.05 versus single
implant). For implantation of >2 stentS the TVR rate was 29% (p c 0.02
versus single stent).
Conclusion: The use of multiple overlapping stents increaaes the likali-
hocd of in-stent restenosis and tha naed for TVR.
D99228 SingleVersusMultiplePalmaz-SchatzStentImplentetion:ImmediateandFollow-upResults
1.Moussa’, C. Di Mario, J. Moaes 1, B. Reimera, S. Blengino, A. Colombo.
Centro Cuore Columbus, Milan, Italy, 1Lenox Hill Hospital, NY USA
Purpose: to evaluate outcome of patients undergoing single versus multiple
Palmaz-Schatz (PS) atent implantation. Methods: 575 consecutive pts (703
lesions) had PS stents implantad and expanded at high pressure. Lesions
withs 1stentcomprised group I (n =445) and Iesionswith >1 stentcomprised
group II (n= 256). Angiographic measurements were as follows:
Group I GroupH
Pre reference diametar (mm) 3.25 k 0.57 3.2S4C0.56
Pre MLD (mm) 1.07+ 0.57” 0.87+0.56*
Prs Lesionlength(mm) 7.67%4.13” 12.21 +S.32”
Final MLD (mm) 3,24 k 0.53 3.23 +0.60
*P <0.05 is consideredsignificant.MLD, minimumlumendiameter.
Procedural sueeesa was 96%. Stent thrombosis occurred in 6 pts, 0.7% in
group I and 1.9% in group II (P= O.12).Angiographic FUwas 73%at 5+ 2 mo
and clinical FU was 95’%0at 8 + 3 mo. Group II had higher restanosis (29%
vs 15Y0,p = 0.0004) USing >50Y0diameter StenOSiSCritefiOn and had higher
need for target lesion revascularization (20% vs 12%, p = 0.002) than group
L In conclusion, lesions requiring multiple stants have higher restenosis than
lesions treatad with a single stent, however this rate is improved from historic




V. Mathew, D. Hasdai, D.E. Grill, S.J. Melby, D.R. Holmes, Jr., P.B.Berger.
Mayo Clinic, Rcehestec MN, USA
The implantation of multiple cordigoua intracoronary stents is increasing
in frequency, although the outcome of such pts is not well described. We
reviewed our experience of 45 consecutive pts (mean 3.5 stentelpt, range 3-
6) without prior CABG orstenting who received 23stents in asinglecoronafy
artery. Palmaz-Schatz, Cook, and Wiktor stents were placed in 64%, 647.,
and 4% of pts, respectively. Indication for Stenting was threatenedacute
closure in 25 pts (56%); the treatad vessel was the RCA in 34 pts (76%).
Multivessel disease was presant in 26 pts (58%); other vessels were treated
in 6 pts (13%). As this included our early experience, 214 atms inflations
were used in only 30 pts (67Yo);warfarin was used post-stent in 25 pts (56%).
In-hospital events included death in 2 pts (4.4%), Q wave Ml in 1 pt (2.2%),
CABG in 2 pts (4.4%), stant occlusion in 4 pts (6.9%), and repeat target
vessel PTCA in 2 pta (4.4%); any of these occurred in 7 pts (15.6%). There
were 41 (91%) successful (no Q wave Ml or CABG) hospital survivors. No
further events occurred in the subsequent W days. Of successful hospital
survivors, 31 pts had ?6 month follow-up; in this period, death occurred in
1 (3.2%), Ml in 2 (6.5%), CABG in 1 (3.2%), stent occlusion in O, target
vessel PTCA in 5 (16.1%), savera angina in 7 (22.5Yo);8 pts (25.6%) had
z-1event. Conclusions: Implantation of multiple stents, even in the presence
of threatened/acute closure, is associated with a high initial success rate,
although early stent thrombosis was a problem. All early evente occurred
ip hospital. At 6 months of follow-up, multiple stent implantation appears to
have an acceptable event rate, although recurrent severe angina and the
need for repeat procedures are limitations of this strategy.
1992-SO]si~-Month~o,,o~-”POfpatientSwithMU!tipie
Stentsina SingleCoronaryArtery
E. Gaxiola, R.E. Vlietstra, K,F. Browne, D.G. Ebereole, A.S. Brenner,
T.T.Weeks, R.A. Kerensky. Watson C/inic, Lake/and, FL, USA, Univeraify of
Florida, Gainesville, FL, USA
Recent studies have shown that placement of a aingle coronary stent (S)
results in a decreased need for repeat target lesion revascularization (RTLR)
compared to PTCA. Placement of a single stent is also associated with high
initial success rates and excellent event free suwival (EFS); EFS is defined
as the absence of myocerdial infarction (Ml), death (D), repeat target Ieaion
angioplasty (RPTCA) or CABG, over a six-month follow-up. Many patients,
however, require multiple stents within a single corona~ artery. Outcome
data in patients receiving multiple stents are lacking. We compared event
free survival and RTLR (repeat PTCA or CABG) between patients (pta)
receiving 1 (n = 320) or multiple (22) adjacent Palmaz-Schatz stants in a
single coronary artery (2S = 115 pts; 3S = 15; 4S = 12; 5S = 3; 6S = 2). Pte
with acute major mmplieetions (n = 17) were excluded.
#sr#Pts EFS (“A) RPTCA (%) CABG (“A) RTLR % Ml (%) D (%)
1/320 275 036) 16 (5.6) 15 (4.7) 10,3 7 (2.2) S (2.6)
2/115 67 ~76j 16(13.9) 10 i6,7j 22.6 0 (0) 2 il.7j
22/147 110 (75) 19 (12.9) 13 (s.s) 21 ,s 2(1 .4) 3 (2.0)
?3/32 23 (72) 3 (9.4) 3 (9.4) 18.8 2 (6.2) 1 (3.1)
1S vs 2S: EFS p <0,025,RPTCA p c 0.01, RTLR p c 0.005, CABG p= NS,1S va 22S:
EFS p <0.01, RPTCA p <0.025, RTLR p <0.005, CABG p = NS; 2S VS ?2S p= NS; 2S
vs ?3S P = NS
Pts raceiving 2 or more stents in a single coronaty artery more frequently
required RTLR and had lower EFS than single stent pts. No difference wee
found in pts receiving 2S vs >2S. We conclude that pts requiring multiple
stents in a single coronaty artery have a lower EFS and significantly more
frequent requirement for RTLR compared with aingle stent pts. Using multiple
stents to decrease restenosis rate may not carry the same long-term benefits
demonstrated with single stents.
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J.E. Tcheng, A.M. Lincoff, D.P.Miller, J.E. Booth, M.M. Rund, C.F. Cabot,
H.F.Weisman, R.M. Califf, E.J. Topoi. Duke Urriv, Durham, NC, USA
The EPIC trial documented a 34.6Y0reduction at 30 days in ischemic com-
plications of coronary intervention with platelet GP llb/llla blockade with
abciximab (c7E3 Fab, ReoPro). The EPILOG trial of weight-adjusted c7E3
151 D<.oolD=.003 D=.041
unstsble stabls recent Ml
sngina ischemia (n=579)
(n=1328) (n=865)
Death, Ml, or urgentinterventionto 30 daya
